Miller GJ - Search Results

1

Phase II evaluation of cisplatin and etoposide followed by mitotane at disease progression in patients with locally advanced or metastatic adrenocortical carcinoma: a Southwest Oncology Group Study.

Williamson SK, Lew D, Miller GJ, Balcerzak SP, Baker LH, Crawford ED. Williamson SK, et al. Among authors: miller gj. Cancer. 2000 Mar 1;88(5):1159-65. Cancer. 2000. PMID: 10699907 Clinical Trial.

2

A phase II trial of dexamethasone, vitamin D, and carboplatin in patients with hormone-refractory prostate cancer.

Flaig TW, Barqawi A, Miller G, Kane M, Zeng C, Crawford ED, Glodé LM. Flaig TW, et al. Cancer. 2006 Jul 15;107(2):266-74. doi: 10.1002/cncr.21982. Cancer. 2006. PMID: 16779800 Free article. Clinical Trial.

3

Impact of different variables on the outcome of patients with clinically confined prostate carcinoma: prediction of pathologic stage and biochemical failure using an artificial neural network.

Ziada AM, Lisle TC, Snow PB, Levine RF, Miller G, Crawford ED. Ziada AM, et al. Cancer. 2001 Apr 15;91(8 Suppl):1653-60. doi: 10.1002/1097-0142(20010415)91:8+<1653::aid-cncr1179>3.0.co;2-b. Cancer. 2001. PMID: 11309764

4

Prostate specific antigen density in patients with histologically proven prostate carcinoma.

Nishiya M, Miller GJ, Lookner DH, Crawford ED. Nishiya M, et al. Among authors: miller gj. Cancer. 1994 Dec 1;74(11):3002-9. doi: 10.1002/1097-0142(19941201)74:11<3002::aid-cncr2820741118>3.0.co;2-g. Cancer. 1994. PMID: 7525041

5

Combination transurethral resection, systemic chemotherapy, and pelvic radiotherapy for invasive (T2-T4) bladder cancer unsuitable for cystectomy: a phase I/II Southwestern Oncology Group study.

Einstein AB Jr, Wolf M, Halliday KR, Miller GJ, Hafermann M, Lowe BA, Meyers FJ, Leimert JT, Crawford ED. Einstein AB Jr, et al. Among authors: miller gj. Urology. 1996 May;47(5):652-7. doi: 10.1016/s0090-4295(96)00019-2. Urology. 1996. PMID: 8650861 Clinical Trial.

6

Neoadjuvant therapy before radical prostatectomy for clinical T3/T4 carcinoma of the prostate: 5-year followup, Phase II Southwest Oncology Group Study 9109.

Powell IJ, Tangen CM, Miller GJ, Lowe BA, Haas G, Carroll PR, Osswald MB, DeVERE WHITE R, Thompson IM Jr, Crawford ED. Powell IJ, et al. Among authors: miller gj. J Urol. 2002 Nov;168(5):2016-9. doi: 10.1016/S0022-5347(05)64285-1. J Urol. 2002. PMID: 12394698

7

High Gleason scores and lower prostate-specific antigen levels in a single institution over the past decade.

Abouelfadel Z, Miller GJ, Glode LM, Akduman B, Donohue RE, Nedrow A, Crawford ED. Abouelfadel Z, et al. Among authors: miller gj. Clin Prostate Cancer. 2002 Sep;1(2):115-7. doi: 10.3816/cgc.2002.n.013. Clin Prostate Cancer. 2002. PMID: 15046702

8

Bilateral orchiectomy with or without flutamide for metastatic prostate cancer.

Eisenberger MA, Blumenstein BA, Crawford ED, Miller G, McLeod DG, Loehrer PJ, Wilding G, Sears K, Culkin DJ, Thompson IM Jr, Bueschen AJ, Lowe BA. Eisenberger MA, et al. N Engl J Med. 1998 Oct 8;339(15):1036-42. doi: 10.1056/NEJM199810083391504. N Engl J Med. 1998. PMID: 9761805 Free article. Clinical Trial.

9

Strategies for chemoprevention of prostate cancer.

Kelloff GJ, Lieberman R, Brawer MK, Crawford ED, Labrie F, Miller GJ, Kelloff GJ. Kelloff GJ, et al. Among authors: miller gj. Prostate Cancer Prostatic Dis. 1999 Jan;2(S1):27-33. doi: 10.1038/sj.pcan.4500274. Prostate Cancer Prostatic Dis. 1999. PMID: 12496854

10

A new method for assaying antimicrobials in the prostate.

Philpott AC, Crawford ED, Miller GJ. Philpott AC, et al. Among authors: miller gj. Infection. 1991;19 Suppl 3:S150-3. doi: 10.1007/BF01643686. Infection. 1991. PMID: 2055651

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

572 results

Search Page

Filters